Drug Supply Chain: You’ve Got Mail? FedEx Launches Life Sciences Org

Research evidence excerpt

Drug Supply Chain: You’ve Got Mail? FedEx Launches Life Sciences Org

Deutsche Bank

Research

North America Industry Date

United States 9 July 2026

Drug Supply Chain

Health Care Industry Update

Healthcare Technology &

Distribution

You’ve Got Mail? FedEx Launches Life

Sciences Org

George Hill

More Ways to Get Drugs: FedEx Launches New Segment: FedEx recently

Research Analyst

announced the launch of its Life Sciences organization, aimed at supporting the +1-212-250-7822

distribution of pharmaceuticals, medical devices, biologics, clinical trials, and other

healthcare shipments. The new segment will be led by long-time FedEx leader, Nick Liz Li

Research Associate

Gennari, who assumes the role of president of healthcare and life sciences. Gennari

+1-617-251-2782

joined FedEx in 1992 and has most recently led the healthcare vertical beginning in

2024. The new initiative builds upon FedEx's recent investments, including Maxi Ma, CFA

achieving IATA CEIV Pharma certification, opening global Life Sciences Centers, Research Associate

and deploying its FedEx Surround monitoring platform, signaling a strategic focus +1-901-338-2175

on capturing a larger share of the healthcare logistics market it already serves with

~$10B in global revenue. Our covered drug distributors, MCK, CAH, and COR, all

traded down low-single-digits on the day of the announcement.

Wholesaling Likely Safe, 3PL Competition to Come: The recent FedEx

announcement is a meaningful move towards competing in the drug supply chain,

but we do not see risk to the core wholesaling and specialty businesses of our

covered distributors, as wholesaling and third-party logistics businesses (3PL) are

very different. We do not believe at this moment that FedEx would want to